Comunicati Stampa
Salute e Benessere

Survey: Unsustainable Regulatory Workloads Leave No Choice About AI Adoption

The study, conducted by Censuswide in September, is striking both in its confirmation of how vital AI-powered process change has become, and in its revelations about persistent barriers that are compromising companies' regulatory transformations. That is as soaring workloads overwhelm already-overstretched teams. The study, conducted by Censuswide in September, is striking both in its confirmation of how vital AI-powered process change has become, and in its revelations about persistent...
BOSTON, (informazione.it - comunicati stampa - salute e benessere)

The study, conducted by Censuswide in September, is striking both in its confirmation of how vital AI-powered process change has become, and in its revelations about persistent barriers that are compromising companies' regulatory transformations. That is as soaring workloads overwhelm already-overstretched teams.

ArisGlobal commissioned the exclusive survey of senior US regulatory professionals in pharma/biopharma companies to examine the growing appetite for AI within an RA context.

The survey identified a series of perceived barriers still holding RA departments back from investing or expanding their investments in AI, even where these are now unjustified, e.g.

Budget, on the other hand, is far less of an issue.

Confirming that companies' perceptions have not kept up with AI's progress, respondents said they would be more proactive about adopting AI in RA if:

Senior regulatory professionals DO see AI in their futures, meanwhile:

The full survey report, The Imperative to Automate: Unsustainable Regulatory Workloads Leave No Choice About AI Adoption , will shortly be available to download from the ArisGlobal web site at https://www.arisglobal.com/ . As well as a full analysis of the findings, the report includes practical recommendations on how life sciences regulatory functions can embrace AI capabilities today within their existing IT environments.

This report is based on an exclusive survey conducted for ArisGlobal by Censuswide between August 30 and September 06, 2024 . The research was conducted among a sample of 100 US respondents in senior regulatory roles at pharma/biopharma companies.

ArisGlobal, an innovative life sciences technology company and creator of LifeSphere , is transforming the way today's most successful life sciences companies develop breakthroughs and bring new products to market. Headquartered in the United States , ArisGlobal has regional offices in Europe , India , Japan , and China . For more updates, follow ArisGlobal on LinkedIn or visit www.arisglobal.com

View original content: https://www.prnewswire.co.uk/news-releases/survey-unsustainable-regulatory-workloads-leave-no-choice-about-ai-adoption-302302747.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili